A stock market authorisation alone is not enough to get a company listed. For Renaprov Finance, a Cameroonian microfinance institution, the first listing announced for 11 November 2026 did not take place. The case highlights a decisive step in financial markets: before shares can be traded, the regulator must still lift its reservation.
A regional operation under regulatory supervision
Renaprov is based in Cameroon, but its project concerns a common market shared by several Central African economies. The Central African Securities Exchange (BVMAC) hosts securities from the Economic and Monetary Community of Central Africa (CEMAC), which comprises six countries that share, among other things, a central bank and a currency.
The Central African Financial Market Supervisory Commission (COSUMAF) oversees this regional market. Its no-objection is a separate condition from the admission decision made by BVMAC: without it, the planned date for trading to begin does not become an effective listing.
This distinction matters to savers and businesses. Admission authorises access to the market in principle, but does not guarantee that trading will begin or that the shares will be liquid. Liquidity means the ability to buy or sell a security without major difficulty.
BVMAC’s approval remained conditional
BVMAC’s admissions committee had set 11 a.m. on 11 November 2026 for Renaprov’s listing on the E-PME segment, which is intended for small and medium-sized enterprises. Its decision, adopted on 16 October and published on 29 October, remained explicitly conditional on COSUMAF’s no-objection.
According to Renaprov Deputy Chief Executive Ferdinand Mbala Ndongo, the institution was still awaiting the decision. He said the listing could take place within five days of the no-objection. BVMAC, for its part, included Renaprov among the securities announced for that date, but this did not confirm that trading had actually begun.
The change is notable compared with the first review of the application. On 5 August 2026, BVMAC’s committee refused to approve the listing “as it stood”. It had notably requested clarification about a land dispute, the approval of the statutory auditor and the proposed listing segment.
After discussions with the exchange and clarifications provided by the company, the application was reviewed again. The October decision selected the E-PME segment. It also requires Renaprov to appoint, within six months of its first listing, a “listing sponsor” approved by COSUMAF to assist the company with its stock market obligations. An agreement with one or more brokerage firms to support trading must also help encourage transactions.
Fundraising well below the initial target
The first public offering, which opened in December 2025, offered 400,000 shares at 21,000 CFA francs each, with a fundraising target of 8.4 billion CFA francs. However, when the operation closed, 52,019 shares had been subscribed, amounting to 1.092 billion CFA francs. Confirmed by BVMAC data, this figure represents a fraction of the initial target.
The admission decision covers 58,919 shares with a declared total value of 1.237 billion CFA francs. This figure should not be confused with the first offering of 400,000 securities: it corresponds to the volume selected for admission after a new fundraising operation mentioned in the decision. Investors therefore have reason to distinguish between the initial targets, the amounts actually raised and the securities due to be listed.
For Renaprov, stronger equity capital could support lending and the institution’s development. For its clients—particularly small-scale entrepreneurs and economic players who have less access to conventional bank loans—the financing capacity of their institution could have tangible effects. But the scale of those effects will depend on the resources actually raised and how they are used.
A test for SME financing in Central Africa
Renaprov’s listing would have sent a signal to companies in the sub-region seeking to diversify their funding beyond bank loans. The E-PME segment aims to provide a stock market route for companies smaller than the major groups already listed. However, it cannot by itself resolve the obstacles to market access: preparing accounts, transparency, governance and sufficient trading between investors remain essential.
Renaprov’s experience also shows that access to the stock market involves several levels of oversight. BVMAC reviews admission and trading arrangements, while COSUMAF supervises the regional financial market. This division of responsibilities may slow the process, but it is intended to regulate information and protect investors.
As of 12 November 2026, the available information shows that the deadline announced the previous day was missed and that COSUMAF’s no-objection was still awaited, according to Renaprov’s executive. The next decisive step is therefore formal confirmation from the regulator, followed by an announcement of the actual listing date. Without these actions, BVMAC’s conditional approval cannot be presented as an effective stock market listing.



